These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26625228)

  • 1. [Use of direct oral anticoagulants in the elderly].
    Mickley F; Geigenmüller G; Schinköthe C
    Dtsch Med Wochenschr; 2015 Dec; 140(24):1810-2. PubMed ID: 26625228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Direct oral anticoagulants and drug-drug interactions].
    Graf L; Korte W
    Ther Umsch; 2015 Feb; 72(2):99-104. PubMed ID: 25630291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of vitamin K antagonists in the elderly].
    Belleville T; Pautas É; Gaussem P; Siguret V
    Ann Biol Clin (Paris); 2014; 72(2):185-92. PubMed ID: 24736138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential antidotes for reversal of old and new oral anticoagulants.
    Suryanarayan D; Schulman S
    Thromb Res; 2014 May; 133 Suppl 2():S158-66. PubMed ID: 24862137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of anticoagulants in elderly patients.
    Bauersachs RM
    Thromb Res; 2012 Feb; 129(2):107-15. PubMed ID: 22014849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticoagulation therapy and the use of non-vitamin K antagonist oral anticoagulants in the elderly].
    Öngen Z
    Turk Kardiyol Dern Ars; 2017 Sep; 45(Suppl 5):86-88. PubMed ID: 28976390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.
    Guo Y; Lip GY; Apostolakis S
    Hosp Pract (1995); 2013 Feb; 41(1):71-8. PubMed ID: 23466969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Novel oral anticoagulants and atrial fibrillation in the elderly].
    Hanon O
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):34-40. PubMed ID: 24463062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral anticoagulants: managing the hemorrhagic risk after 75 years].
    Pautas É
    Rev Prat; 2015 Sep; 65(7):897-9. PubMed ID: 26619720
    [No Abstract]   [Full Text] [Related]  

  • 10. New oral anticoagulants in elderly patients with atrial fibrillation.
    Deedwania PC
    Am J Med; 2013 Apr; 126(4):289-96. PubMed ID: 23369212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What is the current use of vitamin K antagonists in the elderly?].
    Vidal JS; Hanon O
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):17-22. PubMed ID: 24463060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.
    Seiffge DJ; Hooff RJ; Nolte CH; Béjot Y; Turc G; Ikenberg B; Berge E; Persike M; Dequatre-Ponchelle N; Strbian D; Pfeilschifter W; Zini A; Tveiten A; Næss H; Michel P; Sztajzel R; Luft A; Gensicke H; Traenka C; Hert L; Scheitz JF; De Marchis GM; Bonati LH; Peters N; Charidimou A; Werring DJ; Palm F; Reinhard M; Niesen WD; Nagao T; Pezzini A; Caso V; Nederkoorn PJ; Kägi G; von Hessling A; Padjen V; Cordonnier C; Erdur H; Lyrer PA; Brouns R; Steiner T; Tatlisumak T; Engelter ST;
    Circulation; 2015 Sep; 132(13):1261-9. PubMed ID: 26232277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulants. Old and new.
    Levi M; Eerenberg ES; Kampuisen PW
    Hamostaseologie; 2011 Nov; 31(4):229-35. PubMed ID: 21687916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral anticoagulation with vitamin K antagonists].
    Alberio L
    Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.
    Senoo K; Lip GY
    Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should new oral anticoagulants replace low-molecular-weight heparin for thromboprophylaxis in orthopaedic surgery?
    Rosencher N; Bellamy L; Arnaout L
    Arch Cardiovasc Dis; 2009 Apr; 102(4):327-33. PubMed ID: 19427610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation.
    Zoppellaro G; Granziera S; Padayattil Jose S; Denas G; Bracco A; Iliceto S; Pengo V
    Expert Opin Drug Saf; 2015 May; 14(5):683-95. PubMed ID: 25803739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic predisposition to bleeding during oral anticoagulants treatment].
    Montes Díaz R; Nantes O; Molina E; Zozaya J; Hermida J
    An Sist Sanit Navar; 2008; 31(3):247-57. PubMed ID: 19165291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Trends of Inpatient Hospitalisation for Significant Haemorrhage in Patients Anticoagulated for Atrial Fibrillation before and after the Release of Novel Anticoagulants.
    Badal M; Aryal MR; Mege J; Chaudhary A; Donato AA
    Heart Lung Circ; 2015 Jan; 24(1):94-7. PubMed ID: 25108758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant management in the cardiovascular setting.
    Verheugt FW
    Fundam Clin Pharmacol; 2012 Feb; 26(1):11-5. PubMed ID: 21831129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.